SGS is investing in a fifth North American Life Science Services lab in Carson, CA. The 8,000-sq.-ft. Life Science Services GMP/GLP lab will provide microbiological testing and bioanalytical services. The new facility will include 6,000 sq. ft. of dedicated lab space and 2,000 sq. ft. of office space. The facility is projected to open 3Q14 and will initially employ seven scientific staff, with room to expand.
 
“We are very pleased to undertake this project because it allows SGS to establish a West Coast, Life Science Services presence to address the California pharmaceutical and biotechnology market,” said Jeff McDonald, chief operating officer, SGS North America.
 
“This development permits SGS to leverage the bioanalytical testing expertise from the laboratory in Poitiers, France, where SGS has more than 700 validated bioanalytical assays to date,” added Anne Hays, executive vice president, Life Science Services.
 
SGS has 20 labs offering contract analytical and bioanalytical services and is present in North America, Europe, and Asia. SGS also provides clinical trial management (Phase I to IV) and services encompassing data management and statistics, PK/PD modeling and simulation, pharmacovigilance and regulatory consultancy.